Corcept Therapeutics (CORT) Inventory Average (2012 - 2026)

Corcept Therapeutics (CORT) has 15 years of Inventory Average data on file, last reported at $12.9 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 3.82% year-over-year to $12.9 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (down 3.82% YoY), and the FY2025 full-year result was $12.6 million, up 25.51% from the prior year.
• Inventory Average improved to $12.9 million in Q1 2026, from $12.6 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $13.4 million in Q1 2025 to a low of $5.0 million in Q1 2022.
• A 5-year average of $8.7 million and a median of $7.6 million in 2023 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average soared 79.49% in 2025 and decreased 3.82% in 2026, its largest moves.
• Tracing CORT's Inventory Average over 5 years: stood at $6.1 million in 2022, then gained by 25.5% to $7.6 million in 2023, then surged by 34.24% to $10.2 million in 2024, then increased by 23.24% to $12.6 million in 2025, then increased by 2.15% to $12.9 million in 2026.
• Business Quant data shows CORT's Inventory Average at $12.9 million in Q1 2026, $12.6 million in Q4 2025, and $12.3 million in Q3 2025.